Eli Lilly Stock 2026: Foundayo, Retatrutide, Zepbound & Valuation
Eli Lilly’s Q2 revenue jumped 48% to $23 billion as Mounjaro and Zepbound dominated growth. I examine obesity economics, pipeline depth, pricing, manufacturing and LLY valuation.
Eli Lilly’s Q2 revenue jumped 48% to $23 billion as Mounjaro and Zepbound dominated growth. I examine obesity economics, pipeline depth, pricing, manufacturing and LLY valuation.
Coinbase reached record crypto trading market share, $20 billion of average USDC held and 48% of net revenue from subscriptions and services. I examine the Everything Exchange thesis and COIN.
Uber generated $2.8 billion of Q2 free cash flow and more than $10 billion over the last twelve months. I examine platform economics, delivery, robotaxis and UBER valuation.
Apple delivered record June-quarter revenue of $109.4 billion, with iPhone, Mac and Services all setting records. I examine Services, Siri AI, tariffs, margins and AAPL valuation.
Microsoft FY2026 revenue reached $331.8B, Azure grew 43% and commercial RPO hit $678B. The question for MSFT is whether AI capex can keep earning premium returns.
Meta’s Q2 revenue rose 28%, but capex climbed above $31 billion and free cash flow nearly vanished. I examine AI monetization, margins, Reality Labs and META valuation.
AMD’s Q2 revenue jumped 50% and Data Center sales more than doubled. I examine Instinct, EPYC, Helios, margins, AI economics and whether AMD stock still offers value.
Palantir’s Q2 2026 revenue grew 93% as U.S. commercial sales surged 149%. I examine AIP economics, margins, valuation, risks and what PLTR must deliver next.
Keysight’s orders topped $2 billion as AI and high-speed networking drive test demand. Q3 earnings, cash flow, risks and valuation.
Analog Devices is accelerating across industrial and AI data-center markets. Q3 results, cycle risks and ADI stock valuation analyzed.

Independent stock analysis, market research and investing insights — directly to your inbox.